CSIMarket Company Name, Ticker, Customers, else..
 

Viskase Holdings inc   (ENZN)

Viskase Holdings Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ENZN Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Viskase Holdings Inc reported Revenue increase in the 2 quarter 2026 by 17890.22 % year on year.
The sales growth was above Viskase Holdings Inc 's competitors' average revenue growth of 12.51 %, achieved in the same quarter.

• List of ENZN Competitors





Revenue Growth Comparisons




Net Income Comparison

Viskase Holdings inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  ENZN Stock Performance Comparisons





  

Overall company Market Share Q2 2026
Due to outstanding performance in Overall company, revenue grew by 17890.22 % Viskase Holdings inc improved its market share, to approximately 0.33 %.




<<  More on ENZN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Viskase Holdings inc




Gilead Sciences Inc
Share Performance



+23.14%
This Quarter
Gilead Sciences Inc
Profile

Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.

More about Gilead Sciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 191,123.680 mill. $ 30,457.000 mill. $ -3,240.000 mill.


Halozyme Therapeutics Inc
Share Performance



+6.32%
30 Days
Halozyme Therapeutics Inc
Profile

Halozyme Therapeutics Inc is a biotechnology company that primarily focuses on developing and commercializing novel oncology therapies. Their business model involves leveraging their proprietary enzyme technology to improve the delivery and effectiveness of therapeutic drugs. By partnering with pharmaceutical companies, Halozyme aims to license their technology and collaborate on the development and commercialization of innovative therapies for various diseases.

More about Halozyme Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 14,001.545 mill. $ 1,663.738 mill. $ 413.596 mill.


Iovance Biotherapeutics inc
Share Performance



+7.65%
Over The Past 5 Days
Iovance Biotherapeutics inc
Profile

Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients.

More about Iovance Biotherapeutics inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,783.258 mill. $ 324.969 mill. $ -289.517 mill.


Innate Pharma Sa
Share Performance



-0.55%
This Quarter
Innate Pharma Sa
Profile

Innate Pharma SA's business model revolves around the development and commercialization of innovative cancer immunotherapies.

More about Innate Pharma Sa's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 10.086 mill. $ -55.078 mill.


Ladrx Corporation
Share Performance



0.00%
Over The Past 5 Days
Ladrx Corporation
Profile

Ladrx Corporation operates as a global technology solutions provider, offering a range of products and services in various industries. Their business model revolves around leveraging innovative technologies to develop tailored solutions for their clients, with a focus on enhancing operational efficiency and driving digital transformation. By combining their expertise in multiple domains and maintaining strong partnerships, Ladrx aims to deliver value-driven solutions to meet the evolving needs of businesses worldwide.

More about Ladrx Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.005 mill. $ - mill. $ -2.496 mill.

15 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Viskase Holdings inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Viskase Holdings inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.